PharmaShots | Incisive News in 3 Shots

Subscribe Now

XZ.700

Micreos Initiates P-I/IIa Study Evaluating XZ.700 as the World's First Endolysin Therapy for Atopic Dermatitis

Micreos Initiates P-I/IIa Study Evaluating XZ.700 as the World's First Endolysin Therapy for Atopic Dermatitis

September 23, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us